IL1B and type 1 diabetes mellitus: We demonstrate that AS101 and SAS are able to prevent as well as inverse new onset type 1 diabetes in the NOD mouse model, and exhibit effects on α4β7 activity and lymphocyte migration, as well as inhibition of pancreatic IL-1β and IL-17 production and enrichment of T-regulatory (Treg) cells in the islets.